Furthermore, a greater number of MAIT cell clones capable of producing pro-inflammatory cytokines (IL-17, IFN-γ, and GM-CSF) were identified in both peripheral blood and CSF from patients with RRMS compared to control subjects. Here, IL17A is linked to relapsing-remitting multiple sclerosis.